INFLUVAC Tetra 0.5 ml susp inj 15 µg 10 pce

7680680870129 CH-68087 J07BB02
INFLUVAC Tetra 0.5 ml susp inj 15 µg 10 pce
INFLUVAC Tetra 0.5 ml susp inj 15 µg 10 pce
INFLUVAC Tetra 0.5 ml susp inj 15 µg 10 pce
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H1N1)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae A (H3N2)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
kalii chloridum
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
dinatrii phosphas dihydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
calcii chloridum dihydricum
- Substance HNIDK
magnesii chloridum hexahydricum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
2.01 MG Substance HBESI
kalium
0.08 MG Substance HBESI
cetrimidum
- Substance RESI
formaldehydum
- Substance RESI
gentamicini sulfas
- Substance RESI
polysorbatum 80
- Substance RESI
ovalbuminum
- Substance HNIDK

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
68087
Drug name
Influvac Tetra, Injektionssuspension
Galenic form
SUPA
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
28/10/2020
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Influenza, ab 6 Monaten

Packaging details

Description (FR)
INFLUVAC Tetra 0.5 ml susp inj 15 µg 10 pce
Description (DE)
INFLUVAC Tetra 0.5 ml Inj Susp 15 µg 10 Stk
Market launch
19/05/2025
Narcotic (BTM)
No

Other packaging sizes

INFLUVAC TETRA susp inj 2024/25 ser pré 0.5 ml
1 FESP
View
INFLUVAC TETRA susp inj 2024/25 10 ser pré 0.5 ml
10 FESP
View
Buy us a coffee Explore the data